Shell Asset Management’s Usana Health Sciences USNA Stock Holding History

Shell Asset Management’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$37K	Sell	1,337 -2,175	-62%	-$66.9K	﹤0.01%	951
2025 Q2	$107K	Sell	3,512 -379	-10%	-$10.8K	﹤0.01%	985
2025 Q1	$105K	Buy	3,891 +1,829	+89%	+$57.9K	0.01%	1009
2024 Q4	$74K	Hold	2,062	–	–	﹤0.01%	1108
2024 Q3	$78K	Buy	+2,062	New	+$84.7K	﹤0.01%	1103
2024 Q1	$99K	Sell	2,181 -224	-9%	-$11K	﹤0.01%	1025
2023 Q4	$129K	Sell	2,405 -718	-23%	-$36.3K	0.01%	997
2023 Q3	$183K	Sell	3,123 -49	-2%	-$3.06K	0.01%	928
2023 Q2	$200K	Sell	3,172 -966	-23%	-$61.5K	0.01%	918
2023 Q1	$260K	Sell	4,138 -15	-0.4%	-$895	0.01%	843
2022 Q4	$221K	Sell	4,153 -878	-17%	-$47.6K	0.01%	921
2022 Q3	$282K	Sell	5,031 -1,317	-21%	-$87.1K	0.01%	857
2022 Q2	$459K	Buy	6,348 +12	+0.2%	+$894	0.01%	762
2022 Q1	$503K	Sell	6,336 -936	-13%	-$84.4K	0.01%	811
2021 Q4	$736K	Buy	7,272 +37	+0.5%	+$3.69K	0.02%	721
2021 Q3	$667K	Sell	7,235 -310	-4%	-$29.8K	0.02%	726
2021 Q2	$773K	Buy	7,545 +2,526	+50%	+$254K	0.02%	694
2021 Q1	$490K	Sell	5,019 -30	-0.6%	-$2.73K	0.01%	860
2020 Q4	$389K	Hold	5,049	–	–	0.01%	902
2020 Q3	$372K	Hold	5,049	–	–	0.01%	812
2020 Q2	$371K	Sell	5,049 -80	-2%	-$6.28K	0.01%	799
2020 Q1	$296K	Sell	5,129 -80	-2%	-$5.56K	0.01%	877
2019 Q4	$409K	Sell	5,209 -136	-3%	-$10K	0.01%	958
2019 Q3	$366K	Sell	5,345 -44	-0.8%	-$2.95K	0.01%	1007
2019 Q2	$428K	Sell	5,389 -126	-2%	-$9.99K	0.01%	977
2019 Q1	$463K	Hold	5,515	–	–	0.01%	940
2018 Q4	$649K	Sell	5,515 -500	-8%	-$57.8K	0.02%	729
2018 Q3	$725K	Hold	6,015	–	–	0.01%	836
2018 Q2	$694K	Sell	6,015 -327	-5%	-$35.8K	0.01%	837
2018 Q1	$545K	Hold	6,342	–	–	0.01%	889
2017 Q4	$470K	Hold	6,342	–	–	0.01%	923
2017 Q3	$366K	Sell	6,342 -200	-3%	-$11.8K	0.01%	944
2017 Q2	$419K	Hold	6,542	–	–	0.01%	944
2017 Q1	$377K	Sell	6,542 -460	-7%	-$27.5K	0.01%	966
2016 Q4	$429K	Sell	7,002 -62	-0.9%	-$4.04K	0.01%	920
2016 Q3	$489K	Sell	7,064 -318	-4%	-$21K	0.01%	874
2016 Q2	$411K	Sell	7,382 -27,892	-79%	-$1.68M	0.01%	766
2016 Q1	$2.14M	Sell	35,274 -2,108	-6%	-$124K	0.05%	356
2015 Q4	$2.39M	Sell	37,382 -35,208	-49%	-$2.28M	0.06%	329
2015 Q3	$2.67M	Buy	72,590 +3,378	+5%	+$239K	0.04%	363
2015 Q2	$4.73M	Sell	69,212 -3,164	-4%	-$201K	0.09%	224
2015 Q1	$4.02M	Sell	72,376 -214	-0.3%	-$11K	0.07%	266
2014 Q4	$3.72M	Hold	72,590	–	–	0.06%	295
2014 Q3	$2.67M	Buy	72,590 +6,762	+10%	+$244K	0.04%	376
2014 Q2	$2.57M	Sell	65,828 -766	-1%	-$28.4K	0.04%	388
2014 Q1	$2.51M	Sell	66,594 -270	-0.4%	-$9.43K	0.04%	405
2013 Q4	$2.53M	Buy	66,864 +10,810	+19%	+$414K	0.04%	408
2013 Q3	$2.43M	Hold	56,054	–	–	0.04%	420
2013 Q2	$2.03M	Buy	+56,054	New	+$1.7M	0.04%	459

Other funds holding USNA

SWGC

Summit Wealth Group (Colorado) Colorado Springs, Colorado $1.21B AUM 33.48% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Shell Asset Management's USNA Position: Q3 2025 in Review

Shell Asset Management reduced its Usana Health Sciences (USNA) stake by 62% in Q3 2025, selling an estimated $66.9K and leaving 1,337 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #951.

Shell Asset Management first reported a position in USNA in Q2 2013 and has held it in 49 quarters since. The position peaked at $4.73M in Q2 2015. 165 funds tracked by Wall St. Rank hold USNA as of Q3 2025.

Shell Asset Management held 1,337 shares of Usana Health Sciences worth $37K as of Q3 2025.
Shell Asset Management sold 2,175 Usana Health Sciences shares in Q3 2025, an estimated $66.9K.
Usana Health Sciences made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #951 holding.
Shell Asset Management first reported a position in Usana Health Sciences in Q2 2013 and has held it in 49 quarters since.
Shell Asset Management's Usana Health Sciences position peaked at $4.73M in Q2 2015.
165 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.